🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Well deserved, my friend!🤩

Tonight at 6:30pm on Radio 4 - ep 4️⃣ of Best Medicine! Catch Claire Roddie from our City of London Centre, talking about CAR T-Cells and their importance when it comes to treating cancer 🧫 Catch-up later 👉 bbc.co.uk/programmes/m00…

CAR-T cell therapies for T cell malignancies: does cellular immunotherapy represent the best chance of cure? ashpublications.org/bloodadvances/…

To mark #WorldCancerDay, our friends at @UCLmedsci are hosting a virtual event on Transforming Cancer Care (6 February) featuring UCL Alumni Chris van Tulleken 🏳️‍🌈, Paul Maciocia, and other @UCL experts at the frontiers of cancer research. Register: bit.ly/3COG7bw

My PhD paper finally out today! Tweetorial coming but here is the link for now. Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia | Sci Trans Med science.org/doi/10.1126/sc… Paul Maciocia UCL Cancer Institute Cancer Research UK Science, Space & Robots

Nicola PhD paper finally out today after years and years of work. Hugely proud and it’s a cool story too. She will do a tweetorial soon! @nicolamaciocia UCL UCL Cancer Institute CRUKCOLcentre Science Magazine UK Research and Innovation science.org/doi/10.1126/sc…

Up next we have Nicola Maciocia UCL Translational Research Office on anti-CD21 #CART cells for T-ALL #YoungEHA #BSH25 - room M4!

thelancet.com/journals/lanha… Happy to share 15 year follow-up of our study of early rituximab vs watchful waiting for advanced stage, asymptomatic, low tumour burden FL. Substantial delay in TTNT highlights the value of early R for pts seeking to defer/avoid chemo. #lymsm #lymphoma

Focused on improving relapsed/refractory T-ALL patient outcomes, Maciocia et al. identified CD21 as a promising target for CAR T cell therapy. bit.ly/4iG2uie  Nicola Maciocia Cancer Research UK  Paul Maciocia